PRODUCT DETAIL

Rivaroxaban/Acetylsalicylic acid Sandoz 2,5 mg/50 mg

Code

3076F

MA number

16/0102/26-S

Product Form:

cps dur 56x2,5 mg/50 mg (fľ.HDPE)

MA Status:

R - Valid Marketing Authorisation

Type of procedure:

Decentralised

MAH, country:

Sandoz Pharmaceuticals d.d., Slovenia

Therapeutic Class:

16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)

ATC:

B	BLOOD AND BLOOD FORMING ORGANS
B01	ANTITHROMBOTIC AGENTS
B01A	ANTITHROMBOTIC AGENTS
B01AF	Direct factor Xa inhibitors
B01AF51	Rivaroxaban and acetylsalicylic

Shelf life:

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10b fixed combination application
MA issued:	25.03.2026
Validity:	25.03.2031
SPC:	SPC_Rivaroxaban_Acetylsalicylic acid Sandoz 2,5 mg_50 mg_03.2026.pdf
PIL:	PIL_Rivaroxaban_Acetylsalicylic acid Sandoz 2,5 mg_50 mg_03.2026.pdf
Safety feature	Yes
Data update:	30.03.2026